DYAZIDE 50mg/25mg Milligram Tablets

Maa: Irlanti

Kieli: englanti

Lähde: HPRA (Health Products Regulatory Authority)

Aktiivinen ainesosa:

TRIAMTERENE, HYDROCHLOROTHIAZIDE

Saatavilla:

Mercury Pharmaceuticals Ltd

ATC-koodi:

C03EA01

INN (Kansainvälinen yleisnimi):

TRIAMTERENE, HYDROCHLOROTHIAZIDE

Annos:

50mg/25mg Milligram

Lääkemuoto:

Tablets

Prescription tyyppi:

Product subject to prescription which may be renewed (B)

Terapeuttinen alue:

Low-ceiling diuretics and potassium-sparing agents

Valtuutuksen tilan:

Authorised

Valtuutus päivämäärä:

1998-04-01

Pakkausseloste

PACKAGE LEAFLET: INFORMATION FOR THE USER
DYAZIDE® 50MG/25MG TABLETS
TRIAMTERENE 50MG AND HYDROCHLOROTHIAZIDE 25MG
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you. Do not pass it on to
others. It may harm them, even if
their symptoms are the same as yours.
If any of the side effects gets serious, or if you notice any side
effects not listed in this leaflet,
please tell your doctor or pharmacist.
IN THIS LEAFLET:
1. What Dyazide Tablets are and what they are used for
2. Before you take Dyazide Tablets
3. How to take Dyazide Tablets
4. Possible side effects
5. How to store Dyazide Tablets
6. Further information
1. WHAT DYAZIDE TABLETS ARE AND WHAT THEY ARE USED FOR
1. WHAT DYAZIDE TABLETS ARE AND WHAT THEY ARE USED FOR
Dyazide Tablets belong to a group of medicines called thiazides, which
act as diuretics. They
make the kidneys remove water from the body and they have the effect
of lowering the blood
pressure.
Dyazide Tablets are used to treat mild to moderate high blood pressure
and they may be used in
combination with other medicines.
They can also be used to treat oedema, which is a build-up of fluid in
the body.
This may occur in many situations, for instance during treatment with
steroids, or with liver and
kidney problems, or with heart failure (when the heart doesn’t pump
efficiently).
2. BEFORE YOU TAKE DYAZIDE TABLETS
BEFORE YOU TAKE DYAZIDE TABLETS
YOU SHOULD NOT BE GIVEN DYAZIDE TABLETS IF YOU:
• know that you are allergic to triamterene and hydrochlorothiazide
or any of the other
ingredients of Dyazide Tablets (see section 6 of this leaflet)
• have a serious liver or kidney disorder (your doctor will advise
you)
• have high levels of potassium in your blood or high levels of
calcium in the blood. Your doctor
will advise you
• have disease of the adrenal glands causing weakness, weight loss
and a deficiency of hormo

Valmisteyhteenveto

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Dyazide 50mg/25mg Tablets.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 50 mg of Triamterene and 25 mg of Hydrochlorothiazide.
Excipient: Contains 0.12mg of Sunset Yellow (E110) per tablet.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Tablet
Peach coloured, compressed, flat circular, bevel-edged tablet with a single scoreline on one surface and the code ‘E93’
on the other.
The scoreline is only to facilitate breaking for ease of swallowing and not to divide into equal doses
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
It is recommended for the treatment of mild to moderate hypertension, alone or in combination with other
antihypertensive drugs. It is also recommended in the control of oedema due to cardiac failure, cirrhosis of the liver or
the nephrotic syndrome. It can also be used to control the oedema associated with corticosteroid treatment, but only
when the concomitant use of diuretics is considered essential.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Route of administration: oral.
Adults: In hypertension
The recommended dosage is one tablet a day after the morning meal. If “Dyazide” is added to already established
therapy with another antihypertensive drug, the dosage of the latter should be reduced, and later adjusted if necessary.
If another antihypertensive drug is added to “Dyazide” therapy, the dosage of the latter will not normally be reduced.
Adults: In oedema
One “Dyazide” tablet a day after the morning meal.
Elderly
Dosage as for adults. “Dyazide” has been widely used and is usually well tolerated in patients over the age of 60 years.
The normally occurring reduction in glomerular filtration with age should be borne i